Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Sanders was Congress's second-largest recipient of pharmaceutical donations in 2016 yet received only individual donations ...

The Economic Survey 2024-25 says on a global pedestal, India has successfully established itself as one of the top 20 medical ...

Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug ...

Super Bowl ads aren’t just entertainment; they’re cultural barometers. They reflect what resonates with audiences, what ...

A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case ...

Engelberg, a former attorney for the generic pharmaceutical industry, and wife Gail M. Engelberg sold their mansion along the ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

The company announced that the Food and Drug Administration (FDA) has approved Journavx, a twice-daily pill that it described as a "highly selective NaV1.8 pain signal inhibitor for the treatment of ...

Ahmed, as a digital marketing leader specializing in health and wellness, how do you see AI reshaping social media marketing for pharmaceutical, ...

The ambitious plans aim to secure medicine supply, accelerate innovation, strengthen clinical research, and reinforce IP ...